APAM vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

APAM

68.8
AI Score
VS
APAM Wins

CNS

59.9
AI Score

Investment Advisor Scores

APAM

69score
Recommendation
HOLD

CNS

60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric APAM CNS Winner
Forward P/E 8.6059 18.4502 APAM
PEG Ratio 1.38 1.6881 APAM
Revenue Growth 8.9% 12.2% CNS
Earnings Growth 18.3% 31.9% CNS
Tradestie Score 68.8/100 59.9/100 APAM
Profit Margin 24.1% 28.8% CNS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

APAM 1M: -15.3% · 3M: -3.6% CNS 1M: -5.5% · 3M: -8.1%

Current Technical Phase

APAM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 28.4 · Price: $34.88

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 36

RSI (14): 35.6 · Price: $73.00

Fundamentals Snapshot

Metric APAM CNS
Market Cap — —
Forward P/E 8.8 18.3
Trailing P/E 8.7 22.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.5% 0.5%
Operating Margin 0.3% 0.3%
EPS 4.18 3.25
Dividend Yield 0.10% 0.04%

Frequently Asked Questions

Based on our detailed analysis, APAM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.